Contact Us | Schedule a Consultation

Papers & Publications

Research papers and clinical publications authored by our specialists

Management of Hepatotoxicity and Utilization of Antitubercular Drugs in Chronic Liver Disease: A Narrative Review

February 2026 · Journal of Nepal Medical Association

64(295):198-205

DOI: 10.31729/jnma.v64i295.9340

Authors:

PT

Pratap Tiwari

Dr. Pukar Thapa

Dr. Pukar Thapa

Hepatologist

The World Health Organization’s “End TB strategy” envisions a world free of tuberculosis (TB), emphasizing early diagnosis, effective treatment, and prevention. The Government of Nepal has incorporated innovative activities into its National Strategic Plan and the “TB Free Initiative.” Despite...

Management of Hepatotoxicity and Utilization of Antitubercular Drugs in Chronic Liver Disease: A Narrative Review

February 2026 · Journal of Nepal Medical Association

64(295):198-205

DOI: 10.31729/jnma.v64i295.9340

Authors:

PT

Pratap Tiwari

Dr. Pukar Thapa

Dr. Pukar Thapa

Hepatologist

The World Health Organization’s “End TB strategy” envisions a world free of tuberculosis (TB), emphasizing early diagnosis, effective treatment, and prevention. The Government of Nepal has incorporated innovative activities into its National Strategic Plan and the “TB Free Initiative.” Despite...

"Dabigatran Induced severe Esophagitis in a Patient with Budd–Chiari Syndrome: A Case Report"

February 2026 · Advanced Research in Gastroenterology & Hepatology

22

DOI: 10.19080/ARGH.2026.22.556083

Authors:

Dr. Pukar Thapa

Dr. Pukar Thapa

Hepatologist

Clinical response to Rifaximin amongst irritable bowel syndrome (IBS) patients at tertiary level hospital in Nepal

June 2024 · Journal of Patan Academy of Health Sciences

11(1):21-26

DOI: 10.3126/jpahs.v11i1.65652

Authors:

Prof. Dr. Binod Karki

Prof. Dr. Binod Karki

Gastroenterologist & Hepatologist

TS

Tshering Sherpa

RD

Rajeeb Deo

Dr. Pukar Thapa

Dr. Pukar Thapa

Hepatologist

Introduction: Irritable Bowel Syndrome (IBS) is common in patients with abdominal symptoms resulting in significant healthcare expenses. The diagnosis relies on ROME criteria, emphasizing recurrent abdominal pain over three months with changes in defecation patterns and stool appearance. Various treatment...

Predictors of treatment response in cirrhotic patients with overt hepatic encephalopathy

August 2022 · Journal of Patan Academy of Health Sciences

9(2):34-41

DOI: 10.3126/jpahs.v9i2.48078

Authors:

RS

Roshan Shrestha

SK

Sanjit Karki

MS

Manoj Sah

NP

Nandu Poudyal

AK

Ajit Khanal

Prof. Dr. Binod Karki

Prof. Dr. Binod Karki

Gastroenterologist & Hepatologist

Introduction: Hepatic encephalopathy (HE) is a frequent complication and one of the most debilitating manifestations of liver cirrhosis, which negatively impacts patient survival. This study aims to identify the factors influencing the treatment response in patients with liver cirrhosis and...